A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis
Results of this study support the potential use of dexamethasone insert as a physician-administered, preservative-free treatment for AC, with significant improvements in ocular itching and conjunctival redness compared with placebo. The dexamethasone insert was generally safe with a favorable safety profile.
Authors
- Eugene McLaurin (ORCID: https://orcid.org/0000-0002-5437-5903)
- Erik Anderson
- Steven Silverstein (ORCID: https://orcid.org/0000-0002-8243-2485)
- Srilatha Vantipalli (ORCID: https://orcid.org/0000-0002-4108-5149)
- Ravi H Patel
- Michael H. Goldstein (ORCID: https://orcid.org/0000-0001-6672-3752)
- Paul J Gomes (ORCID: https://orcid.org/0000-0002-1421-0186)
- Erin Reilly (ORCID: https://orcid.org/0000-0003-1343-6439)
- Kenneth R. Kenyon
- Matthew W Cheung
- John C Meyer
Institutions
- Andover Eye Associates (US)
- The Eye Care Institute (US)
- Eye Care Associates (US)
- Houston Eye Associates (US)
- Star Center (US)
- Total Rehab (US)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/opth.s476419
- Citations
- 2
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 1.09